Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zharf Andishan Fanavar Zist Bespar is an Iranian biotechnology company specializing in the development and manufacture of advanced biomaterials and wound care solutions. The company leverages a proprietary biopolymer platform, primarily utilizing chitosan and other natural polymers, to create bioactive dressings for chronic wounds, burns, and surgical applications. Their product portfolio includes advanced wound care systems designed to accelerate healing and provide antimicrobial protection. As a recognized knowledge-based enterprise, the company focuses on translating tissue engineering research into clinical applications for regenerative medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zharf Andishan Fanavar Zist Bespar.